Publications by authors named "Eudocia Q Lee"

74Publications

Immune Checkpoint Inhibitor with or without Radiotherapy in Melanoma Patients with Brain Metastases: A Systematic Review and Meta-Analysis.

Korean J Radiol 2020 Nov 26. Epub 2020 Nov 26.

Department of Radiology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
November 2020

Neurologic Complications in Patients With Cancer.

Authors:
Eudocia Q Lee

Continuum (Minneap Minn) 2020 12;26(6):1629-1645

View Article and Find Full Text PDF
December 2020

WNT-Activated Medulloblastomas With Hybrid Molecular Subtypes.

JCO Precis Oncol 2020 14;4. Epub 2020 Apr 14.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article and Find Full Text PDF
April 2020

Advances in Management of Brain and Leptomeningeal Metastases.

Curr Neurol Neurosci Rep 2020 06 6;20(7):26. Epub 2020 Jun 6.

Center for Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article and Find Full Text PDF
June 2020

Mechanisms and therapeutic implications of hypermutation in gliomas.

Nature 2020 04 15;580(7804):517-523. Epub 2020 Apr 15.

Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article and Find Full Text PDF
April 2020

To add IT chemotherapy, or not to add, that is the question.

Authors:
Eudocia Q Lee

Neuro Oncol 2020 04;22(4):442-443

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article and Find Full Text PDF
April 2020

PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade glioma.

Neurology 2018 10 31;91(14):e1355-e1359. Epub 2018 Aug 31.

From the Laura and Isaac Perlmutter Cancer Center (S.C.K.), Brain Tumor Center, NYU Langone Medical Center, New York; Dana-Farber Cancer Institute (L.P.C., D.H., M.R., L.N., E.Q.L., D.A.R., P.Y.W.), Center for Neuro-Oncology; and Department of Radiology (R.H., P.U.), Brigham and Women's Hospital, Boston, MA.

View Article and Find Full Text PDF
October 2018

The Interface Between Neurology and Oncology.

Neurol Clin 2018 08 13;36(3):xiii-xiv. Epub 2018 Jun 13.

Center for Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, D2, Boston, MA 02215, USA; Division of Cancer Neurology, Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. Electronic address:

View Article and Find Full Text PDF
August 2018

Brain Metastases.

Neurol Clin 2018 08 18;36(3):557-577. Epub 2018 Jun 18.

Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA; Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. Electronic address:

View Article and Find Full Text PDF
August 2018

The Evolving Landscape of Brain Metastasis.

Trends Cancer 2018 03 21;4(3):176-196. Epub 2018 Feb 21.

Department of Neuro-Oncology, University Hospital Turin, Via Cherasco 15, 10126 Turin, Italy. Electronic address:

View Article and Find Full Text PDF
March 2018

Brain Tumors.

Am J Med 2018 08 31;131(8):874-882. Epub 2018 Jan 31.

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Mass; Department of Neurology, Brigham and Women's Hospital, Boston, Mass; Harvard Medical School, Boston, Mass. Electronic address:

View Article and Find Full Text PDF
August 2018

Response Assessment in Neuro-Oncology Clinical Trials.

J Clin Oncol 2017 Jul 22;35(21):2439-2449. Epub 2017 Jun 22.

Patrick Y. Wen and Eudocia Q. Lee, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Susan M. Chang, University of California, San Francisco, San Francisco, CA; Michael A. Vogelbaum, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH; Martin J. Van den Bent, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands; and David R. Macdonald, London Regional Cancer Program, Western University, London, Ontario, Canada.

View Article and Find Full Text PDF
July 2017

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.

Neuro Oncol 2017 Oct;19(11):1511-1521

Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts; Department of Biostatistics, Harvard T. H. Chan School of Public Health, and Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Department of Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

View Article and Find Full Text PDF
October 2017

Corticosteroids for peritumoral edema: time to overcome our addiction?

Neuro Oncol 2016 09 16;18(9):1191-2. Epub 2016 Aug 16.

Center for Neuro-Oncology, Dana-Farber / Brigham and Women's Cancer Center, Boston, MA (E.Q.L., P.Y.W.); Harvard Medical School, Boston, MA (E.Q.L., P.Y.W.).

View Article and Find Full Text PDF
September 2016

Updates in the management of brain metastases.

Neuro Oncol 2016 08;18(8):1043-65

St. Luke's Radiation Oncology Associates, St. Luke's Cancer Center, Whiteside Institute for Clinical Research and University of Minnesota Duluth, Duluth, Minnesota (N.D.A.); Center for Neuro-Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts (E.Q.L., P.Y.W.); Harvard Medical School, Boston, Massachusetts (E.Q.L., B.M.A., N.U.L., I.F.D., P.Y.W.); Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland (M.P.M.); Department of Medical Oncology, City of Hope, Duarte, California (K.M.); Department of Radiation Oncology, Dana-Farber/Brigham & Women's Cancer Center, Boston, Massachusetts (B.M.A.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (N.U.L.); Department of Medicine, Division of Hematology-Oncology, University of North Carolina, Chapel Hill, North Carolina (C.K.A.); Department of Neurology/Neuro-Oncology, University of Turin, Turin, Italy (R.S.); Division of Medical Oncology, University of Colorado Denver, Denver, Colorado (D.R.C.); Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio (M.A.V.); Department of Neurosurgery, Brigham & Women's Hospital, Boston, Massachusetts (I.F.D.).

View Article and Find Full Text PDF
August 2016

Assessment of Brain Tumor Response: RANO and Its Offspring.

Curr Treat Options Oncol 2016 07;17(7):35

Department of Neuro-Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.

View Article and Find Full Text PDF
July 2016

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.

Neuro Oncol 2016 06 21;18(6):849-54. Epub 2016 Feb 21.

Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (E.Q.L., D.A.R., A.D.N., L.N., M.L.R., B.M.A., N.D.A., L.D., J.S., D.L., S.F.R., J.P., K.H.S., S.C.G., S.H., P.Y.W.); Harvard Medical School, Boston, Massachusetts (E.Q.L., E.T.W., D.A.R., A.D.N., L.N., M.L.R., B.M.A., N.D.A., P.Y.W.); Massachusetts General Hospital, Boston, Massachusetts (A.M.); University of Pittsburgh, Pittsburgh, Pennsylvania (J.D.); University of California San Diego, La Jolla, California (S.K.); Beth Israel Deaconess Medical Center, Boston, Massachusetts (E.T.W.); Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire (C.E.F.); Geisel School of Medicine at Dartmouth, Hanover, New Hampshire (C.E.F.).

View Article and Find Full Text PDF
June 2016

A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.

Neuro Oncol 2016 Feb 30;18(2):269-74. Epub 2015 Aug 30.

Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (A.A.A., M.C.H., N.D.A., B.M.A.); Department of Pathology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (M.A., K.L.L., A.H.L., S.S.); Department of Neurosurgery, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (W.L.B., O.A-M., I.F.D.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (E.Q.L., L.N., M.L.R., A.D.N., D.A.R., P.Y.W., R.B.).

View Article and Find Full Text PDF
February 2016

Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate Differentiation.

World Neurosurg 2016 Jan 28;85:96-105. Epub 2015 Jul 28.

Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:

View Article and Find Full Text PDF
January 2016

Computationally simple analysis of matched, outcome-based studies of ordinal disease states.

Stat Med 2015 Jul 22;34(17):2514-27. Epub 2015 Apr 22.

Brain Tumor Center, Massachusetts General Hospital, Boston, MA, U.S.A.

View Article and Find Full Text PDF
July 2015

Nervous system metastases from systemic cancer.

Authors:
Eudocia Q Lee

Continuum (Minneap Minn) 2015 Apr;21(2 Neuro-oncology):415-28

View Article and Find Full Text PDF
April 2015

Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.

Neuro Oncol 2015 Oct 9;17(10):1344-55. Epub 2015 Mar 9.

Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.H.R., L.A.R., S.H., D.K., Y.J.K., K.L.L.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (S.E.S., L.B., M.B., D.A.R., E.Q.L., M.L.R., A.D.N., L.N., S.R., L.M.D., D.C.L., P.K., B.J.R., P.Y.W., R.B., K.L.L.); Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts (W.L.B., E.B.C, O.A.-M., M.D.J., A.J.G., I.F.D., E.A.C.); Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts (L.T.); Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts (M.H., A.A.A., N.D.A., B.M.A.); Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (M.H., A.A.A., N.D.A., B.M.A.); Harvard Radiation Oncology Program, Boston, Massachusetts (A.R.); Kravis Center for Molecular Oncology & Department of Epidemiology and Biostatistics, Memorial Sloan- Kettering Cancer Center, New York, New York (N.S.); Broad Institute, Cambridge, Massachusetts (R.B.); Department of Pathology, Boston Children's Hospital, Boston, Massachusetts (K.L.L.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., A.D., J.B.C., M.A., S.S., R.D.F., N.I.L., A.H.L., K.L.L.)

View Article and Find Full Text PDF
October 2015

Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma.

Neuro Oncol 2015 Jun 7;17(6):862-7. Epub 2015 Jan 7.

Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (E.Q.L., D.A.R., A.D.N., L.N., R.B., M.L.R., K.H., C.M., K.H.S., S.C.G., B.W., K.L.L., P.Y.W.); University of Virginia, Charlottesville, Virginia (D.S.); University of Pittsburgh, Pittsburgh, Pennsylvania (J.D.); Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (A.S.C., T,T.B., A.M.); Central DuPage Hospital, Warrenville, Illinois (S.A.G.); Northwestern University, Chicago, Illinois (J.J.R.).

View Article and Find Full Text PDF
June 2015

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.

Neurology 2015 Jan 19;84(3):280-6. Epub 2014 Dec 19.

From the Division of Cancer Neurology, Department of Neurology (A.D.N., E.Q.L., P.Y.W.), and Departments of Pathology (K.L.L.) and Medicine (R.B.), Brigham and Women's Hospital, Boston, MA; Center for Neuro-Oncology (A.D.N., S.N.H., D.A.R., R.B., E.Q.L., L.D., D.L., M.G., K.H.S., C.M., P.Y.W.), Dana-Farber/Brigham and Women's Cancer Center; Department of Medicine (R.B.), Harvard Medical School (A.D.N., K.L.L., D.A.R., T.T.B., S.R.P., E.T.W., R.B., E.Q.L., P.Y.W.), Boston; Department of Medical Oncology, Center for Molecular Oncologic Pathology (K.L.L., S.H.), and Departments of Medical Oncology and Cancer Biology (R.B.), Dana-Farber Cancer Institute, Boston; Massachusetts General Hospital Biostatistics Center (A.M.); Brain Tumor Center (T.J.K.), Memorial Sloan-Kettering Cancer Center, New York, NY; Pappas Center for Neuro-Oncology (T.T.B., S.R.P.), Massachusetts General Hospital, Boston; Department of Neurology (J.J.R.), Northwestern University Feinberg School of Medicine, Chicago, IL; Brain Tumor Center (E.T.W.), Beth-Israel Deaconess Medical Center, Boston; Adult Neuro-Oncology Program (J.D.), University of Pittsburgh Medical Center, Pittsburgh, PA; Comprehensive Cancer Center (G.J.L.), Wake Forest University Baptist Medical Center, Winston-Salem, NC; and Departments of Neurosurgery and Neurology (S.P.), Cedars-Sinai Medical Center, Los Angeles, CA.

View Article and Find Full Text PDF
January 2015

Medical management of brain tumors and the sequelae of treatment.

Neuro Oncol 2015 Apr 30;17(4):488-504. Epub 2014 Oct 30.

Neuro-Oncology Center, University of Virginia Medical Center, Charlottesville, Virginia (D.S.); Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts (E.Q.L., L.N., A.D.N., D.A.R., P.Y.W.).

View Article and Find Full Text PDF
April 2015

Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab.

Neuro Oncol 2014 Nov 23;16(11):1523-9. Epub 2014 Jun 23.

Harvard Medical School, Boston, Massachusetts (R.R., A.D.N., D.A.R., L.N., M.L.R., R.B., B.M.A., R.Y.H., P.Y.W., E.Q.L.); Center of Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (K.H., A.D.N., D.A.R., L.N., M.L.R., R.B., L.D., S.R., J.R., D.L., P.Y.W., E.Q.L.); Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts (A.D.N., D.A.R., L.N., M.L.R., R.B., P.Y.W., E.Q.L.); Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts (B.M.A.); Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts (R.Y.H.); Boston University School of Medicine, Boston, Massachusetts (A.R.).

View Article and Find Full Text PDF
November 2014

Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma.

Neuro Oncol 2014 Nov 2;16(11):1547-53. Epub 2014 Jun 2.

Harvard Radiation Oncology Program, Brigham and Women's Hospital, Boston, Massachusetts (A.A.A.); Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (N.D.A., B.M.A.); Department of Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts (P.C.); Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts (E.B.C., A.J.G., M.D.J., O.A-M., I.F.D.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (P.Y.W., D.A.R., E.Q.L., L.N., M.L.R., R.B.); Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania (S.E.W.); Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (S.H.R., S.S., M.A.).

View Article and Find Full Text PDF
November 2014

Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma.

J Neurooncol 2013 Oct 5;115(1):71-7. Epub 2013 Jul 5.

Department of Neuro-Oncology, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing, China.

View Article and Find Full Text PDF
October 2013

Update on bevacizumab and other angiogenesis inhibitors for brain cancer.

Expert Opin Emerg Drugs 2013 Jun 14;18(2):137-53. Epub 2013 May 14.

Dana-Farber/Brigham and Women's Cancer Center, Center for Neuro-Oncology, Boston, MA, USA.

View Article and Find Full Text PDF
June 2013

Treatment options in newly diagnosed glioblastoma.

Curr Treat Options Neurol 2013 Jun;15(3):281-8

Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article and Find Full Text PDF
June 2013

Current and future directions for Phase II trials in high-grade glioma.

Expert Rev Neurother 2013 Apr;13(4):369-87

Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, 75 Francis Street, ASB1-L2, Boston, MA 02115, USA.

View Article and Find Full Text PDF
April 2013

PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussion.

J Neurooncol 2013 May 12;113(1):143-7. Epub 2013 Mar 12.

Department of Internal Medicine and Markey Cancer Center, University of Kentucky, Lexington, KY, USA.

View Article and Find Full Text PDF
May 2013

Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial.

JAMA Ophthalmol 2013 Apr;131(4):514-21

Department of Ophthalmology and Vision Sciences, University of Toronto, St Michael’s Hospital, Toronto, Canada.

View Article and Find Full Text PDF
April 2013

Bayesian adaptive randomized trial design for patients with recurrent glioblastoma.

J Clin Oncol 2012 Sep 29;30(26):3258-63. Epub 2012 May 29.

Dana-Farber Cancer Institute, Harvard School of Public Health and Dana-Farber/ Brigham and Women's Cancer Center, Boston, MA 02215, USA.

View Article and Find Full Text PDF
September 2012

Current clinical development of PI3K pathway inhibitors in glioblastoma.

Neuro Oncol 2012 Jul 22;14(7):819-29. Epub 2012 May 22.

Center For Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

View Article and Find Full Text PDF
July 2012

Central nervous system complications of cancer therapy.

J Support Oncol 2012 Jul-Aug;10(4):133-41. Epub 2012 Apr 27.

Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.

View Article and Find Full Text PDF
September 2012